Skin Analytics raised £15M in Series B funding. The company, led by Intrepid Partners, plans to use the funds for hiring, launching products, and expanding internationally.
Skin Analytics raised £15M in Series B funding. The company, led by Intrepid Partners, plans to use the funds for hiring, launching products, and expanding internationally.
04/16/25, 4:48 PM
Location
londonMoney raised
£15 million
Industry
medical
artificial intelligence
biotechnology
health care
Round Type
series b
Investors
Intrepid Partners
Skin Analytics, a London, UK-based medtech company, raised £15m in Series B funding. The round was led by Intrepid Partners. The company intends to use the funds to hire new people, launch dermatology products, as well as expand internationally to new markets including Europe and Australia, and prepare for US market launch. Led by Neil Daly, founder and CEO, the company is advancing a Class IIa UKCA marked and Class III CE marked AI as a Medical Device that assesses dermoscopic images of skin lesions for skin cancer.
Company Info
Location
london, england, united kingdom
Additional Info
Skin Analytics is a medtech company focused on advancing artificial intelligence for the assessment of skin lesions. It has developed DERM, an AI as a Medical Device that helps in detecting skin cancer through dermoscopic image analysis. The company aims to improve patient care and efficiency within the NHS by prioritizing patients at risk of skin cancer. With recent funding, Skin Analytics plans to expand its product offerings and reach international markets.